Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Discipline topic

No spam. Unsubscribe anytime.

Nevada Pharmacy Board revokes, suspends and fines multiple licensees in June hearings

Nevada State Board of Pharmacy · June 1, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Over two days the Board issued revocations, suspensions, probation orders and fines — including immediate revocations for two technicians, a stayed revocation with probation for a pharmacist, and penalties for pharmacies and an outsourcing firm — as part of a packed disciplinary docket.

The Nevada State Board of Pharmacy heard a series of disciplinary matters June 3–4 and issued a range of orders including revocations, stayed revocations with probation, fines and assessments for attorney fees.

Notable outcomes include: Hilco Vision (License WH02862) — $2,500 fine and $1,000 in attorney fees (due July 1, 2026) for distribution of ophthalmic products from a non‑FDA‑registered manufacturer (motion approved); Patricia Sanchez (Certificate PT28814) — revocation for one year and $1,118.15 in fees; Joseph Steidl (Certificate No. 18852) — revocation for one year and $190.95 in fees; Darlene Hess (PT27744) — revocation for one year and $1,268.54 in fees. Pharmacist Jose Escobedo received a stayed revocation and two‑year probation with a $5,000 fine, $1,000 in fees and a requirement to complete four ethics continuing‑education hours. Antonino Gumina was placed on two‑year probation, fined $5,000, assessed $1,000 in fees, and ordered to complete PMP training and a six‑month follow up. For Walgreens Pharmacy #03922 the Board assessed a $2,000 fine and $1,000 in attorney fees and amended the probation conditions for employee Mona Matar (suspension stayed; two‑year probation; $2,000 fine; $1,000 fees).

The Board also resolved a complex matter involving PharMerica and individual employee Camilla Kim: the Board found PharMerica guilty on one count (Count Four) with amendments to the accusation and not guilty on other counts; it assessed fines and allocated attorney‑fee responsibility among the parties. In the Camilla Kim matters the Board approved a stipulation (revocation stayed; probation through June 30, 2028; $1,000 fine; $1,500 fees; professional monitoring and quarterly reports). Across the disciplinary docket motions were typically moved by Board counsel and adopted unanimously or with recorded individual votes where noted.